Search research articles
Contact Us
Filters
Showing results (11-20 of 126) with videos related to
Page
of 13
Sort By:
Seminars in Hematology
|
January 9, 2008
DNA methyltransferase and histone deacetylase inhibitors in the treatment of myelodysplastic syndromes
Elizabeth A Griffiths, Steven D Gore
Blood Advances
|
November 15, 2018
When to obtain genomic data in acute myeloid leukemia (AML) and which mutations matter
Gregory W Roloff, Elizabeth A Griffiths
Hematology. American Society of Hematology. Education Program
|
December 4, 2018
When to obtain genomic data in acute myeloid leukemia (AML) and which mutations matter
Gregory W Roloff, Elizabeth A Griffiths
Future Oncology (London, England)
|
March 12, 2021
Role of cedazuridine/decitabine in the management of myelodysplastic syndrome and chronic myelomonocytic leukemia
Swapna Thota, Aram Oganesian, Mohammad Azab, et al.
IEEE Transactions on Bio-Medical Engineering
|
July 15, 2016
Automated Assessment of Disease Progression in Acute Myeloid Leukemia by Probabilistic Analysis of Flow Cytometry Data
Bartek Rajwa, Paul K Wallace, Elizabeth A Griffiths, et al.
Critical Reviews in Oncology/Hematology
|
November 25, 2015
Polo-like kinase inhibitors in hematologic malignancies
Chetasi Talati, Elizabeth A Griffiths, Meir Wetzler, et al.
International Journal of Technology Assessment in Health Care
|
May 22, 2023
Demonstrating proof of concept for value-based agreements in Europe: two real-world cases
Elizabeth A Griffiths, Onivefu E Odelade, Joana Gostkorzewicz, et al.
Current Hematologic Malignancy Reports
|
October 6, 2021
Application of Next-Generation Sequencing-Based Mutational Profiling in Acute Lymphoblastic Leukemia
Ahmed Aleem, Ali R Haque, Gregory W Roloff, et al.
Leukemia Research
|
March 9, 2020
Advances in non-intensive chemotherapy treatment options for adults diagnosed with acute myeloid leukemia
Elizabeth A Griffiths, Hetty E Carraway, Namrata S Chandhok, et al.
Blood Reviews
|
March 23, 2011
Interpretation of cytogenetic and molecular results in patients treated for CML
Carlos E Vigil, Elizabeth A Griffiths, Eunice S Wang, et al.
Page
of 13
Search research articles
Search
Showing results (11-20 of 126) with videos related to
Sort By:
Page
of 13
Seminars in Hematology
|
January 9, 2008
DNA methyltransferase and histone deacetylase inhibitors in the treatment of myelodysplastic syndromes
Elizabeth A Griffiths, Steven D Gore
Blood Advances
|
November 15, 2018
When to obtain genomic data in acute myeloid leukemia (AML) and which mutations matter
Gregory W Roloff, Elizabeth A Griffiths
Hematology. American Society of Hematology. Education Program
|
December 4, 2018
When to obtain genomic data in acute myeloid leukemia (AML) and which mutations matter
Gregory W Roloff, Elizabeth A Griffiths
Future Oncology (London, England)
|
March 12, 2021
Role of cedazuridine/decitabine in the management of myelodysplastic syndrome and chronic myelomonocytic leukemia
Swapna Thota, Aram Oganesian, Mohammad Azab, et al.
IEEE Transactions on Bio-Medical Engineering
|
July 15, 2016
Automated Assessment of Disease Progression in Acute Myeloid Leukemia by Probabilistic Analysis of Flow Cytometry Data
Bartek Rajwa, Paul K Wallace, Elizabeth A Griffiths, et al.
Critical Reviews in Oncology/Hematology
|
November 25, 2015
Polo-like kinase inhibitors in hematologic malignancies
Chetasi Talati, Elizabeth A Griffiths, Meir Wetzler, et al.
International Journal of Technology Assessment in Health Care
|
May 22, 2023
Demonstrating proof of concept for value-based agreements in Europe: two real-world cases
Elizabeth A Griffiths, Onivefu E Odelade, Joana Gostkorzewicz, et al.
Current Hematologic Malignancy Reports
|
October 6, 2021
Application of Next-Generation Sequencing-Based Mutational Profiling in Acute Lymphoblastic Leukemia
Ahmed Aleem, Ali R Haque, Gregory W Roloff, et al.
Leukemia Research
|
March 9, 2020
Advances in non-intensive chemotherapy treatment options for adults diagnosed with acute myeloid leukemia
Elizabeth A Griffiths, Hetty E Carraway, Namrata S Chandhok, et al.
Blood Reviews
|
March 23, 2011
Interpretation of cytogenetic and molecular results in patients treated for CML
Carlos E Vigil, Elizabeth A Griffiths, Eunice S Wang, et al.
Page
of 13